#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15424	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2073	739.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1418	1418	C	944	C	842	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15424	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2073	739.7	0	HET	.	.	.	C207T	.	207	207	C	441	441	C	872	C,T	612,157	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15424	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2073	739.7	0	HET	.	.	.	C451T	.	451	451	C	685	685	C	951	C,T	670,179	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15424	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2073	739.7	0	HET	.	.	.	C1036T	.	1036	1036	C	1270	1270	C	921	C,T	616,220	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28222	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3361	835.7	0	.	n	.	0	T695C	SNP	695	695	T	946	946	C	911	C,T	807,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28222	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3361	835.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2222	2222	C	944	C,A,T	832,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28222	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3361	835.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2296	2296	A	890	A	813	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28222	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3361	835.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2848	2848	C	807	C	733	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	28222	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3361	835.7	0	HET	.	.	.	A1638G	.	1638	1638	A	1889	1889	A	932	A,G	662,191	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1796	folP	855	855	100.0	folP.l6.c30.ctg.1	1609	111.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1052	1054	AGC	197;202;199	A;G;C	182;184;180	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5122	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3222	158.3	1	SNP	p	S91F	1	.	.	271	273	TTC	478	480	TTC	184;185;186	T,G;T;C	165,1;167;171	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5122	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3222	158.3	1	SNP	p	D95G	1	.	.	283	285	GGC	490	492	GGC	180;180;178	G;G;C	165;166;163	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5122	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3222	158.3	1	SNP	p	G95N	0	.	.	283	285	GGC	490	492	GGC	180;180;178	G;G;C	165;166;163	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1564	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1118	138.2	1	SNP	p	G45D	0	.	.	133	135	GGC	409	411	GGC	195;196;194	G;G;C	172;173;173	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	702	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	884	78.8	0	.	n	.	0	A197.	DEL	197	197	A	566	566	A	164	A	147	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6244	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2887	215.5	1	SNP	p	D86N	0	.	.	256	258	GAC	473	475	GAC	243;244;248	G;A;C	214;207;219	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6244	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2887	215.5	1	SNP	p	S87R	1	.	.	259	261	CGT	476	478	CGT	253;255;259	C;G,A;T	224;224,1;227	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6244	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2887	215.5	1	SNP	p	R87I	0	.	.	259	261	CGT	476	478	CGT	253;255;259	C;G,A;T	224;224,1;227	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6244	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2887	215.5	1	SNP	p	R87W	0	.	.	259	261	CGT	476	478	CGT	253;255;259	C;G,A;T	224;224,1;227	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6244	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2887	215.5	1	SNP	p	S88P	0	.	.	262	264	TCC	479	481	TCC	262;262;260	T;C;C	223;234;233	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4168	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2588	160.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1526	1528	GGC	208;204;205	G;G;C	186;179;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1309	1311	GCC	217;218;221	G;C;C	189;188;189	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1312	1314	ATG	221;220;220	A;T;G	190;189;187	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1324	1326	ACC	216;221;225	A;C;C	185;193;197	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1324	1326	ACC	216;221;225	A;C;C	185;193;197	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1825	1827	ACC	209;207;211	A;C;C	183;184;187	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1879	1881	GCG	211;213;212	G;C;G,T	188;187;186,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1879	1881	GCG	211;213;212	G;C;G,T	188;187;186,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2002	2004	GGT	157;159;158	G;G;T	140;140;140	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2011	2013	AGC	147;147;147	A;G;C	134;132;130	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	3898	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2408	161.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2029	2031	CCG	138;139;139	C,G;C,G;G,T	101,5;105,2;104,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5998	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	2819	211.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1472	1474	CCG	243;244;240	C;C;G	209;215;198	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2418	porA	1146	1146	99.91	porA.l15.c17.ctg.1	1601	149.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	468	468	C	176	C	157	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3080	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1524	201.4	1	SNP	p	G120K	1	.	.	358	360	AAG	620	622	AAG	229;226;229	A;A;G	204;203;203	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3080	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1524	201.4	1	SNP	p	N121D	0	.	.	361	363	AAC	623	625	AAC	228;227;228	A;A;C	205;205;205	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3080	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1524	201.4	1	SNP	p	A121N	1	.	.	361	363	AAC	623	625	AAC	228;227;228	A;A;C	205;205;205	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11668	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4648	250.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1270	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	978	128.7	1	SNP	p	V57M	1	.	.	169	171	ATG	470	472	ATG	284;284;284	A;T;G,T	244;243;245,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
